BlueRock Therapeutics has signed a long-term lease for approximately 80,000 square feet at Catalyst, Seeker Labs’ purpose-built life sciences facility at 77 Wade Ave. in Toronto’s Junction neighbourhood.

The lease makes BlueRock Therapeutics the anchor tenant at the 155,000-square-foot development and marks a significant milestone as the project nears completion.

Developed by Seeker, Catalyst is Toronto’s first privately funded, purpose-built life sciences facility delivered in more than 20 years. The building is designed to support advanced laboratory and research uses, including wet lab and clinical research operations.

“We are pleased to welcome BlueRock Therapeutics to Catalyst,” said Cary Solomon, managing partner of Seeker Labs. “Their commitment reflects the quality of the facility and reinforces the continued demand for institutional-grade life sciences infrastructure in Toronto.”

Founded in 2016, BlueRock has maintained research, development and manufacturing operations in Toronto and is now a wholly owned, independently operated subsidiary of Bayer AG. The company focuses on developing cell therapies for the treatment of degenerative diseases and will customize its space at Catalyst to support its research, clinical development and manufacturing activities.

Catalyst was designed to meet the operational requirements of leading life sciences organizations, with infrastructure tailored to advanced laboratory environments and scalable research operations, said Seeker.

In addition, said Seeker, BlueRock’s lease commitment reflects accelerating growth in Canada’s life sciences sector and increasing demand for specialized research facilities across the Greater Toronto Area.

Catalyst is the first project within Seeker Labs’ broader national life sciences platform, with additional developments planned across Canada.

Pictured: Seeker’s purpose-built laboratory project in Toronto.

Image: Seeker Labs

If you’re making investment, development, or lending decisions in today’s Canadian commercial real estate market, Connect CRE Canada in Toronto on June 25 is where you need to be. Join an audience of 200 investors, lenders, brokers, developers, and owners for high-level networking and timely discussions on the trends impacting today’s market. Hear from industry leaders at TD Asset Management, Starlight, Woodbourne Capital Management, REMAX, Fengate Asset Management, Stonebridge Financial, Yardi, and more. Register now to gain the insights and connections to navigate an evolving landscape.